Literature DB >> 10759444

N-acetylcysteine prevents cigarette smoke induced small airways alterations in rats.

M L Rubio1, M V Sanchez-Cifuentes, M Ortega, G Peces-Barba, J D Escolar, S Verbanck, M Paiva, N González Mangado.   

Abstract

This study investigated the effect of cigarette smoke exposure and the potential protection N-acetylcysteine (NAC) in rat lungs. Forty-eight rats were exposed to cigarette smoke (CS) for 10 weeks, without (CS group) or with (CS+NAC group) oral intake of NAC 200 mg x rat(-1) x day(-1), or to fresh air (Control). All rat lungs were assessed in terms of lung function, ventilation distribution (nitrogen, helium and sulphur hexafluoride phase III slopes), and morphometry (airway wall thickening of small, medium and large bronchi). The small bronchi, defined as the airways with an internal perimeter <1,000 microm showed significantly thicker airway walls in the CS than in the Control group. By contrast, no airway wall thickening was observed in the CS+NAC group with respect to Control. Except for decreased lung volumes and compliance in CS and CS+NAC groups, which were entirely attributable to smaller body weight gain, lung function was indistinguishable from Control. Phase III slopes were significantly increased only in the CS group. In conclusion, smoke-induced alterations in the rat lungs were reflected in wall thickening of the small bronchi and increased ventilation maldistribution. These smoke-induced morphometric and ventilation distribution alterations were prevented by N-acetylcysteine.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10759444     DOI: 10.1034/j.1399-3003.2000.15.13.x

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  4 in total

Review 1.  Update on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary disease.

Authors:  Hoi Nam Tse; Cee Zhung Steven Tseng
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-08-06

2.  Proliferative activity of liver growth factor is associated with an improvement of cigarette smoke-induced emphysema in mice.

Authors:  Álvaro Girón-Martínez; Sandra Pérez-Rial; Raúl Terrón-Expósito; Juan José Díaz-Gil; Nicolás González-Mangado; Germán Peces-Barba
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

3.  Exposure to second-hand smoke is an independent risk factor of small airway dysfunction in non-smokers with chronic cough: A retrospective case-control study.

Authors:  Bingrong Zhao; Lu Bai; Rongjun Wan; Yanan Wang; Ling Qin; Qiming Xiao; Pinhua Pan; Chengping Hu; Juan Jiang
Journal:  Front Public Health       Date:  2022-07-20

Review 4.  The role for N-acetylcysteine in the management of COPD.

Authors:  P N R Dekhuijzen; W J C van Beurden
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.